Business Description
Artiva Biotherapeutics Inc
NAICS : 325412
SIC : 2834
Description
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.55 | |||||
Equity-to-Asset | -1.54 | |||||
Debt-to-Equity | -0.1 | |||||
Debt-to-EBITDA | -0.6 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.54 | |||||
Beneish M-Score | 3.27 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -17.1 | |||||
3-Year EPS without NRI Growth Rate | -17.7 | |||||
3-Year FCF Growth Rate | -54.2 | |||||
3-Year Book Growth Rate | -44.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.82 | |||||
9-Day RSI | 66.05 | |||||
14-Day RSI | 59.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.53 | |||||
Quick Ratio | 6.53 | |||||
Cash Ratio | 6.3 | |||||
Days Sales Outstanding | 8.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -35.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -91.58 | |||||
Net Margin % | -82.69 | |||||
FCF Margin % | -151.34 | |||||
ROA % | -23.26 | |||||
ROIC % | -85.84 | |||||
3-Year ROIIC % | -49.32 | |||||
ROC (Joel Greenblatt) % | -117.39 | |||||
ROCE % | -30.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.36 | |||||
EV-to-EBIT | -8.51 | |||||
EV-to-EBITDA | -9.19 | |||||
EV-to-Revenue | 7.8 | |||||
EV-to-FCF | -5.15 | |||||
Earnings Yield (Greenblatt) % | -11.75 | |||||
FCF Yield % | -17.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARTV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Artiva Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 33.492 | ||
EPS (TTM) ($) | -3.07 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 59.67 | ||
14-Day ATR ($) | 0.698534 | ||
20-Day SMA ($) | 11.0155 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 9.71 - 16 | ||
Shares Outstanding (Mil) | 24.29 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Artiva Biotherapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Artiva Biotherapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Artiva Biotherapeutics Inc Frequently Asked Questions
What is Artiva Biotherapeutics Inc(ARTV)'s stock price today?
The current price of ARTV is $12.02. The 52 week high of ARTV is $16.00 and 52 week low is $9.71.
When is next earnings date of Artiva Biotherapeutics Inc(ARTV)?
The next earnings date of Artiva Biotherapeutics Inc(ARTV) is .
Does Artiva Biotherapeutics Inc(ARTV) pay dividends? If so, how much?
Artiva Biotherapeutics Inc(ARTV) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |